🔎 Trials Near Me

Akèy › Limfòm folikilè › Florid

Etid klinik pou Limfòm folikilè nan Florid

25 etid pou Limfòm folikilè ap chèche patisipan nan sit nan Florid.

Vil nan Florid

Tèks ofisyèl etid la (Anglè)

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • ak 6 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07215910

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Mayo Clinic Jacksonville, Jacksonville
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
  • Tampa General Hospital Cancer Institute, Tampa
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05006716

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

  • Moffitt Cancer Center, Tampa
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06350318

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  • University of Miami - Sylvester Cancer Center, Miami
  • Florida Cancer Specialists - Sarasota, Sarasota
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07226843

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  • Research Site, Jacksonville
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Sep 21, 2026 · NCT06549595

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  • Research Site, Tampa
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06526793

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

  • Mayo Clinic Jacksonville, Jacksonville
  • AdventHealth, Orlando
Ap rekriteFaz 3
Laj 12 a 100 · Tout sèks · Mizajou Sep 11, 2026 · NCT06784752

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • ak 6 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06860594

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

  • Research Site, Miami Lakes
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Sep 1, 2026 · NCT07546760

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • University of Florida Health, Gainesville
  • Mayo Clinic - Florida, Jacksonville
  • University of Miami Health, Miami
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  • Boca Raton Clinical Research (BRCR) Global, Plantation
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT06149286

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

  • Gateway Community Services, Jacksonville
  • IBIS Behavioral Health, Tampa
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06651177

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • Mayo Clinic, Clinical Trials Referral Office, Jacksonville
Ap rekriteFaz 1/2
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • Mayo Clinic, Jacksonville
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07424833

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • University of Miami, Miami
  • Florida Cancer Specialists, Sarasota
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

  • UF Health, Gainesville
Ap rekriteFaz 1
Laj 4 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT04573140

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

  • Orlando Clinical Research Center, Orlando
Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Jun 16, 2026 · NCT07559474

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  • Local Institution - 0008, Jacksonville
  • Local Institution - 0214, Tampa
  • Local Institution - 0217, Tampa
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT06911502

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • ASCLEPES Research Centers, Weeki Wachee
Ap rekriteFaz 1/2
Laj 12 a 95 · Tout sèks · Mizajou Apr 15, 2026 · NCT04329728

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

  • Florida Cancer Specialists and Research Institute, Fort Myers
  • University of Miami, Miami
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 23, 2026 · NCT04998669

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Napa Research, Pompano Beach
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • Mount Sinai Comprehensive Cancer Center, Miami Beach
  • Moffitt Cancer Center, Tampa
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Jacksonville
  • Massive Bio SYNERGY-AI site, Miami
  • Massive Bio SYNERGY-AI site, Tampa
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

  • Florida Cancer Specialists, Sarasota
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05780034

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.